Systems approach reveals distinct and shared signaling networks of the four PGE2 receptors in T cells

Sci Signal. 2021 Oct 5;14(703):eabc8579. doi: 10.1126/scisignal.abc8579. Epub 2021 Oct 5.

Abstract

Prostaglandin E2 (PGE2) promotes an immunosuppressive microenvironment in cancer, partly by signaling through four receptors (EP1, EP2, EP3, and EP4) on T cells. Here, we comprehensively characterized PGE2 signaling networks in helper, cytotoxic, and regulatory T cells using a phosphoproteomics and phosphoflow cytometry approach. We identified ~1500 PGE2-regulated phosphosites and several important EP1–4 signaling nodes, including PKC, CK2, PKA, PI3K, and Src. T cell subtypes exhibited distinct signaling pathways, with the strongest signaling in EP2-stimulated CD8+ cells. EP2 and EP4, both of which signal through Gαs, induced similar signaling outputs, but with distinct kinetics and intensity. Functional predictions from the observed phosphosite changes revealed PGE2 regulation of key cellular and immunological processes. Last, network modeling suggested signal integration between the receptors and a substantial contribution from G protein–independent signaling. This study offers a comprehensive view of the different PGE2-regulated phosphoproteomes in T cell subsets, providing a valuable resource for further research on this physiologically and pathophysiologically important signaling system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dinoprostone
  • Receptors, Prostaglandin E*
  • Signal Transduction
  • Systems Analysis
  • T-Lymphocytes*

Substances

  • Receptors, Prostaglandin E
  • Dinoprostone